The Effect of Antacids on the Pharmacokinetics (PK) of Raltegravir in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-824)
Clinical trial NCT02473367 · COMPLETED
Trial details
- NCT number
- NCT02473367
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-23
- Primary completion
- 2015-08-29
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.